Top

Indian Journal of Thoracic and Cardiovascular Surgery

Published in:

01-01-2018 | Review Article

Key updates from international coronary congress 2016—a review

Authors: Pradeep Narayan, Kunal Sarkar, Naresh Trehan, Praveen Chandra, Nagendra Singh Chouhan, John Daniel Puskas, David Paul Taggart, Om Prakash Yadava

Published in: Indian Journal of Thoracic and Cardiovascular Surgery | Issue 1/2018

Abstract

This review focuses on the key issues raised during the International Coronary Congress (ICC) 2016. The left internal thoracic artery and the drug-eluting stents in relation to the left anterior descending artery re-vascularization have been compared and the role of Heart Team stressed upon. The current role of bilateral internal thoracic artery grafting is discussed. The importance of and tools for intra-operative assessment of graft patency have been outlined. The patency and related issues of saphenous vein grafts harvested using the no-touch technique has been discussed in detail. Following the discussion at ICC 2016 and review of literature, we conclude that left internal thoracic artery remains the best option for left anterior descending artery lesions and for left main and ostial or proximal left anterior descending artery lesions. The Heart Team should be approached for decision making. Bilateral internal thoracic artery usage should be encouraged especially in the Indian population which includes a higher proportion of younger patients with a particularly high prevalence of diabetes. Transit time flowmetry is a useful tool to confirm and assess whether intra-operative graft flow and saphenous vein grafts harvested with a no-touch technique have better patency than conventionally harvested vein grafts.

Otsuka F, Yahagi K, Sakakura K, Virmani R. Why is the mammary so special and what protects it from atherosclerosis? Ann Cardiothorac Surg. 2013;2:519–26.PubMedPubMedCentral

Konishi T, Yamamoto T, Funayama N, Nishihara H, Hotta D. Relationship between left coronary artery bifurcation angle and restenosis after stenting of the proximal left anterior descending artery. Coron Artery Dis. 2016;27:449–59.CrossRefPubMedPubMedCentral

Suwannasom P, Sotomi Y, Ishibashi Y, et al. The impact of post procedural asymmetry, expansion and eccentricity of bioresorbable everolimus eluting scaffold and metallic everolimus eluting stent on clinical outcomes in the ABSORB II trial. JACC Cardiovasc Interv. 2016;9:1231–42.CrossRefPubMed

Gori T, Jansen T, Weissner M, et al. Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome and optical coherence tomography analysis of possible mechanisms. Eur Heart J. 2016;37:2040–9.CrossRefPubMed

Soeda T, Uemura S, Park SJ, et al. Incidence and clinical significance of poststent optical coherence tomography findings: one-year follow-up study from a multicenter registry. Circulation. 2015;132:1020–9.CrossRefPubMed

Ohya M, Kubo S, Kuwayama A, et al. Long term (8–10 years) outcomes after biodegradable polymer-coated biolimus—eluting stent implantation. Heart. 2017;103:1002–8.CrossRefPubMed

Wang XW, Qu C, Huang C, Xiang XY, Lu ZQ. Minimally invasive direct coronary bypass compared with percutaneous coronary intervention for left anterior descending artery disease: a meta-analysis. J Cardiothorac Surg. 2016;11:125.CrossRefPubMedPubMedCentral

Deo SV, Sharma V, Shah IK, Erwin PJ, Joyce LD, Park SJ. Minimally invasive direct coronary artery bypass graft surgery or percutaneous coronary intervention for proximal left anterior descending artery stenosis: a meta-analysis. Ann Thorac Surg. 2014;97:2056–65.CrossRefPubMed

Thiele H, Neumann-Schniedewind P, Jacobs S, et al. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol. 2009;53:2324–31.CrossRefPubMed

10.

Rao C, Aziz O, Panesar SS, et al. Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ. 2007;334:621.CrossRefPubMedPubMedCentral

11.

Rioufol G, Mewton N, Rabilloud M et al. FUTURE: FFR-guided revascularisation vs angioplasty in CAD patients. Paper presented at AHA Annual Scientific Sessions. 2016; November 12–16, 2016; New Orleans, LA.

12.

Ikeno F, Brooks MM, Nakagawa K, et al. SYNTAX score and long term outcomes—the BARI-2D trial. J Am Coll Cardiol. 2017;69:395–403.CrossRefPubMed

13.

Meliga E, De Benedictis M, Chieffo A, et al. Coronary artery bypass graft versus percutaneous coronary intervention with drug eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry. Euro Intervention. 2013;9:803–8.PubMed

14.

Guagliumi G, Shimamura K, Sirbu V et al. TRANSFORM-OCT: a prospective randomized trial using OCT imaging to evaluate strut coverage at 3 months and neo-atherosclerosis at 18 months in bio-resorbable polymer-based and durable polymer-based drug eluting stents. Presented at TCT 2016; November 2, 2016. Washington DC.

15.

Zhang M, Guddeti RR, Matsuzawa Y, et al. Left internal mammary artery versus coronary stents: impact on downstream coronary artery stenosis and conduit patency. J Am Heart Assoc. 2016;5:e003568.CrossRefPubMedPubMedCentral

16.

Kurlansky P, Herbert M, Prince S, Mack M. Coronary artery bypass graft versus percutaneous coronary intervention: meds matter: impact of adherence to medical therapy on comparative outcomes. Circulation. 2016;134:1238–46.CrossRefPubMed

17.

Brener SJ, Kirtane AJ, Stuckey TD, et al. The impact of timing of ischaemic and haemorrhagic events on mortality after percutaneous coronary intervention The ADAPT-DES Study JACC. Cardiovasc Interv. 2016;9:1450–7.CrossRef

18.

Hanratty CG, Walsh SJ. Longitudinal compression: a “new” complication with modern coronary stent platforms—time to think beyond deliverability. Euro Intervention. 2011;7:872–7.PubMed

19.

Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol. 2006;110:7–14.CrossRefPubMed

20.

Egholm G, Kristensen SD, Thim T, et al. Risk associated with surgery within 12 months after coronary drug eluting stent implantation. J Am Coll Cardiol. 2016;68:2622–32.CrossRefPubMed

21.

Dorman MJ, Kurlansky PA, Traad EA, Galbut DL, Zucker M, Ebra G. Bilateral internal mammary artery grafting enhances survival in diabetic patients: a 30-year follow-up of propensity score-matched cohorts. Circulation. 2012;126:2935–42.CrossRefPubMed

22.

Sajja LR, Beri P. Bilateral internal thoracic artery grafting in India—time to raise the bar. Indian Heart J. 2017;http://doi.org/10.1016/j.ihj.2017.03.001

23.

Taggart DP, D’Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet. 2001;358:870–5.CrossRefPubMed

24.

Takagi H, Goto SN, Watanabe T, et al. A meta-analysis of adjusted hazard ratios from 20 observational studies of bilateral versus single internal thoracic artery coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014;148:1282–90.CrossRefPubMed

25.

Kai M, Okabayashi H, Hanyu M, et al. Long-term results of bilateral internal thoracic artery grafting in dialysis patients. Ann Thorac Surg. 2007;83:1666–71.CrossRefPubMed

26.

Pevni D, Ben-Gal Y, Mohr R, et al. One or two internal thoracic grafts? Long-term follow-up of 957 off-pump coronary bypass surgeries. Ann Thorac Surg. 2017;104:70–7.CrossRefPubMed

27.

Taggart DP, Altman DG, Gray AM, et al. ART investigators randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med. 2016;375:2540–9.CrossRefPubMed

28.

Hwang HY, Kim JS, Cho KR, Kim KB. Bilateral internal thoracic artery in situ versus y-composite graftings: five-year angiographic patency and long-term clinical outcomes. Ann Thorac Surg. 2011;92:579–85.CrossRefPubMed

29.

Yanagawa B, Verma S, Jüni P, et al. A systematic review and meta-analysis of in situ versus composite bilateral internal thoracic artery grafting. J Thorac Cardiovasc Surg. 2017;153:1108–16.CrossRefPubMed

30.

Ali E, Saso S, Ashrafian H, Athanasiou T. Does a skeletonized or pedicled left internal thoracic artery give the best graft patency? Interact Cardiovasc Thorac Surg. 2010;10:97–104.CrossRefPubMed

31.

Boodhwani M, Lam BK, Nathan HJ, et al. Skeletonized internal thoracic artery harvest reduces pain and dysesthesia and improves sternal perfusion after coronary artery bypass surgery: a randomized, double-blind, within-patient comparison. Circulation. 2006;22;114:766–73.CrossRef

32.

Cohen AJ, Lockman J, Lorberboym M, et al. Assessment of sternal vascularity with single photon emission computed tomography after harvesting of the internal thoracic artery. J Thorac Cardiovasc Surg. 1999;118:496–502.CrossRefPubMed

33.

Rubens FD, Chen L, Bourke M. Assessment of the association of bilateral internal thoracic artery skeletonization and sternal wound infection after coronary artery bypass grafting. Ann Thorac Surg. 2016;101:1677–82.CrossRefPubMed

34.

Gatti G, Dell’Angela L, Barbati G, et al. A predictive scoring system for deep sternal wound infection after bilateral internal thoracic artery grafting. Eur J Cardiothorac Surg. 2016;49:910–7.CrossRefPubMed

35.

Gatti G, Barbati G, Luzzati R, Sinagra G, Pappalardo A. Prospective validation of a predictive scoring system for deep sternal wound infection after routine bilateral internal thoracic artery grafting. Interact Cardiovasc Thorac Surg. 2016;22:606–11.CrossRefPubMedPubMedCentral

36.

Hol PK, Lingaas PS, Lundblad R, et al. Intraoperative angiography leads to graft revision in coronary artery bypass surgery. Ann Thorac Surg. 2004;78:502–5.CrossRefPubMed

37.

Taggart DP. Biochemical assessment of myocardial injury after cardiac surgery: effects of a platelet activating factor antagonist, bilateral internal thoracic artery grafts, and coronary endarterectomy. J Thorac Cardiovasc Surg. 2000;120:651–9.CrossRefPubMed

38.

Niclauss L. Techniques and standards in intraoperative graft verification by transit time flow measurement after coronary artery bypass graft surgery: a critical review. Eur J Cardiothorac Surg. 2017;51:26–33.CrossRefPubMed

39.

Morota T, Duhaylongsod FG, Burfeind WR, Huang CT. Intraoperative evaluation of coronary anastomosis by transit-time ultrasonic flow measurement. Ann Thorac Surg. 2002;73:1446–50.CrossRefPubMed

40.

Di Giammarco G, Canosa C, Foschi M, et al. Intraoperative graft verification in coronary surgery: increased diagnostic accuracy adding high-resolution epicardial ultrasonography to transit-time flow measurement. Eur J Cardiothorac Surg. 2014;45:e41–5.CrossRefPubMed

41.

Balacumaraswami L, Abu-Omar Y, Choudhary B, Pigott D, Taggart DP. A comparison of transit-time flowmetry and intraoperative fluorescence imaging for assessing coronary artery bypass graft patency. J Thorac Cardiovasc Surg. 2005;130:315–20.CrossRefPubMed

42.

Souza D. A new no-touch preparation technique. Technical notes. Scand J Thorac Cardiovasc Surg. 1996;30:41–4.CrossRefPubMed

43.

Souza DS, Christofferson RH, Bomfim V, Filbey D. “No-touch” technique using saphenous vein harvested with its surrounding tissue for coronary artery bypass grafting maintains an intact endothelium. Scand Cardiovasc J. 1999;33:323–9.CrossRefPubMed

44.

Li FD, Eagle S, Brophy C, et al. Pressure control during preparation of saphenous veins. JAMA Surg. 2014;149:655–62.CrossRefPubMedPubMedCentral

45.

Shuhaiber JH, Evans AN, Masssad MG, Geha AS. Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery. Eur J Cardiothorac Surg. 2002;22:387–96.CrossRefPubMed

46.

Dreifaldt M, Souza D, Bodin L, et al. The vasa vasorum and associated endothelial nitric oxide synthase is more important for saphenous vein than arterial bypass grafts. Angiology. 2013;64:293–9.CrossRefPubMed

47.

Dashwood MR, Dooley A, Shi-Wen X, Abraham DJ, Dreifaldt M, Souza DS. Perivascular fat-derived leptin: a potential role in improved vein graft performance in coronary artery bypass surgery. Interact Cardiovasc Thorac Surg. 2011;12:170–3.CrossRefPubMed

48.

Fd R, Souza D, Lima Rde C, et al. Novel no-touch technique of harvesting the saphenous vein for coronary artery bypass grafting. Arq Bras Cardiol. 2008;90:356–62.

49.

Verma S, Lovren F, Pan Y, et al. Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activation: the PATENT saphenous vein graft study. Eur J Cardiothorac Surg. 2014;45:717–25.CrossRefPubMed

50.

Johansson BL, Souza DS, Bodin L, et al. Slower progression of atherosclerosis in vein grafts harvested with “no touch” technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. Eur J Cardiothorac Surg. 2010;38:414–9.CrossRefPubMed

51.

Souza DS, Dashwood MR, Tsui JC, et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann Thorac Surg. 2002;73:1189–95.CrossRefPubMed

52.

Samano N, Geijer H, Liden M, Fremes S, Bodin L, Souza D. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J Thorac Cardiovasc Surg. 2015;150:880–8.CrossRefPubMed

53.

Johansson B, Samano N, Souza D, et al. The no-touch vein graft for coronary artery bypass surgery preserves the left ventricular ejection fraction at 16 years postoperatively: long-term data from a longitudinal randomised trial. Open Heart. 2015;2:e000204.CrossRefPubMedPubMedCentral

54.

Dreifaldt M, Mannion JD, Bodin L, Olsson H, Zagozdzon L, Souza D. The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting. Ann Thorac Surg. 2013;96:105–11.CrossRefPubMed

55.

Kim YH, Oh HC, Choi JW, Hwang HY, Kim KB. No-touch saphenous vein harvesting may improve further the patency of saphenous vein composite grafts: early outcomes and 1-year angiographic results. Ann Thorac Surg. 2017;103:1489–97.CrossRefPubMed

56.

The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on myocardial revascularization Eur J Cardiothorac Surg. 2010;38:S1–S52.CrossRef

57.

Holmes DR Jr, Rich JB, Zoghbi WA, Mack MJ. The Heart Team of cardiovascular care. J Am Coll Cardiol. 2013;61:903–7.CrossRefPubMed

58.

Park SJ, Kim YH, Park DW, et al. Randomized trial of stent versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011;364:1718–27.CrossRefPubMed

59.

Morice MC, Serruys PW, Kappetein AP, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation. 2014;129:2388–94.CrossRefPubMed

60.

Stone GW, Sabik JF, Serruys PW, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med. 2016;375:2223–35.CrossRefPubMed

Title: Key updates from international coronary congress 2016—a review
Authors: Pradeep Narayan
Kunal Sarkar
Naresh Trehan
Praveen Chandra
Nagendra Singh Chouhan
John Daniel Puskas
David Paul Taggart
Om Prakash Yadava
Publication date: 01-01-2018
Publisher: Springer Singapore
Published in: Indian Journal of Thoracic and Cardiovascular Surgery / Issue 1/2018
Print ISSN: 0970-9134
Electronic ISSN: 0973-7723
DOI: https://doi.org/10.1007/s12055-017-0579-x

At a glance: The STEP trials

Springer Medicine

Key updates from international coronary congress 2016—a review

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Graft patency study in off-pump coronary artery bypass surgery

Traumatic diaphragmatic hernia—17 years experience

Effect of sternal wire twisting on sternotomy closure rigidity

Infiltrative right atrial angiosarcoma

Evaluation of the results of surgery treatment in patients with congenital chest deformity

VSD with severe aortic regurgitation with an anomalous coronary artery: a rare case